Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reggio Emilia study on bromfenac for postoperative inflammation in pseudoexfoliation
2013-002066-39Phase 4Completed
- Sponsor
- Santa Maria Nuova
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bromfenac sodium in cyclitis, pseudoexfoliation syndrome (PXF) and cataract (2 arms), sponsored by Santa Maria Nuova. Primary endpoint: Anterior chamber inflammation reduction. Started Jul 2013; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
cyclitispseudoexfoliation syndrome (PXF)cataract
Beyond the preview
Go deeper on 2013-002066-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002066-39.